Article: NEW THERAPY SHUTS DOWN ALLERGIC REACTIONS

00-00-0000
New therapy shuts down allergic reactions

LOS ANGELES, Apr 30, 2002 (United Press International via COMTEX) -- An experimental therapy to freeze the molecular process that triggers allergic reactions is showing promise in animal studies and could be a potential treatment for humans, researchers reported Tuesday.

Researchers at the University of California at Los Angeles and the University of New Mexico designed a genetically engineered molecule called GE2 that interacts with two types of immune system cells playing key roles in allergic reactions -- basophils and mast cells. The cells respond abnormally to substances such as pollen or animal dander and cause the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!